Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China
Authors
Jinfang Sun
Hongxing Pan (ORCID: https://orcid.org/0000-0002-3791-1241)
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China
Jinfang Sun, Hongxing Pan, Xianyun Chang, Fengcai Zhu et al.
Journal
Expert Review of Vaccines
Topics
Herpesvirus Infections and Treatments
article
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China
Jinfang Sun, Hongxing Pan, Xianyun Chang, Fengcai Zhu, Jinhui Shi, Guifan Li, Yang Zhang, Hao Zhang, Shiyuan Wang, Jingxin Li
article en
Abstract
No abstract available for this paper.
Publication Tag
Expert Review of VaccinesVol. 24(1)
Institutions
Beijing VDJBio (China) (CN), Jiangsu Provincial Center for Disease Control and Prevention (CN)